Insight Molecular Diagnostics (IMDX) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 11.62% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 9.72% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 67.83% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 9.78% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.05% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -0.87% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -2.49% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 1.78% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -1.06% |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | 21.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.40% |
| Mar 31, 2026 | 24.54% |
| Dec 31, 2025 | 46.27% |
| Sep 30, 2025 | 85.66% |
| Jun 30, 2025 | 99.37% |
| Mar 31, 2025 | 102.81% |
| Dec 31, 2024 | 16.34% |
| Sep 30, 2024 | -14.28% |
| Jun 30, 2024 | -57.57% |
| Mar 31, 2024 | -60.11% |
| Dec 31, 2023 | -37.32% |
| Sep 30, 2023 | -64.84% |
| Jun 30, 2023 | -31.86% |
| Mar 31, 2023 | -16.96% |
| Dec 31, 2022 | 1.70% |
| Sep 30, 2022 | 51.80% |
| Jun 30, 2022 | 57.60% |
| Mar 31, 2022 | 46.59% |
| Dec 31, 2021 | 30.70% |
| Sep 30, 2021 | 35.00% |